IP Library Granted Patent US 10,167,489
Granted Patent B2
US 10,167,489 · App. 15/179,253 · Granted Jan 1, 2019

Microbial oils with lowered pour points, dielectric fluids produced therefrom, and related methods

Inventors: Scott Franklin (Woodside, CA); Walter Rakitsky (San Diego, CA); George Rudenko (Mountain View, CA); Xinhua Zhao (Dublin, CA); Felipe Arana Rodriguez (San Mateo, CA); Wenhua Lu (Pacifica, CA); Janice Wee (San Mateo, CA)
Assignee: Corbion Biotech, Inc.
C12P7/6463A23D9/007A23D9/02C10M169/041C11B1/025C11B1/06C11B1/10C11B3/001C11B3/006C11B3/008C11B3/06C11B3/10C11B3/14C12N9/2442C12N15/79C12P7/6409C12Y301/02014H01B3/20H01F27/321H01F27/105
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,167,489
App. No.
15/179,253
Granted
Jan 1, 2019
Kind
B2
Abstract

Methods and compositions for the production of dielectric fluids from lipids produced by microorganisms are provided, including oil-bearing microorganisms and methods of low cost cultivation of such microorganisms. Microalgal cells containing exogenous genes encoding, for example, a sucrose transporter, a sucrose invertase, a fructokinase, a polysaccharide-degrading enzyme, a lipid pathway modification enzyme, a fatty acyl-ACP thioesterase, a desaturase, a fatty acyl-CoA/aldehyde reductase, and/or an acyl carrier protein are useful in manufacturing dielectric fluids.

Claims (24)

1. A method of producing a microalgal oil, the method comprising:

a. cultivating a genetically engineered Chlorella or Prototheca cell engineered to ablate or downregulate expression of an endogenous fatty acyl-ACP thioesterase gene until the microbe has at least 10% oil by dry weight;

b. separating the oil from the microbe; and optionally

c. subjecting the oil to refining, bleaching, deodorizing or degumming to produce RBD microbial oil.

2. The method of claim 1 , wherein the endogenous fatty acyl-ACP thioesterase gene is downregulated by an inhibitory RNA.

3. The method of claim 1 , wherein the Prototheca or Chlorella cell is of the species Prototheca moriformis or Chlorella protothecoides.

4. The method of claim 1 , wherein the Chlorella or Prototheca cell further comprises one or more expressed exogenous genes that encode a sucrose invertase, a fatty acyl-ACP thioesterase or a desaturase.

5. The method of claim 4 , wherein the one or more expressed exogenous genes encode(s) an inhibitory RNA that targets an endogenous desaturase.

6. A method of producing a microalgal oil, the method comprising:

a. cultivating a genetically engineered Chlorella or Prototheca cell engineered to ablate or downregulate expression of an endogenous fatty acyl-ACP thioesterase gene and engineered to express one or more exogenous genes until the microbe has at least 10% oil by dry weight;

b. separating the oil from the microbe; and optionally

c. subjecting the oil to refining, bleaching, deodorizing or degumming to produce RBD microbial oil.

7. The method of claim 6 , wherein the endogenous fatty acyl-ACP thioesterase gene is downregulated by an inhibitory RNA.

8. The method of claim 6 , wherein the one or more expressed exogenous genes encode(s) sucrose invertase, fatty acyl-ACP thioesterase or desaturase.

9. The method of claim 6 , wherein the one or more expressed exogenous genes encode(s) an inhibitory RNA that targets an endogenous desaturase.

10. The method of claim 6 , wherein the Prototheca or Chlorella is of the species Prototheca moriformis or Chlorella protothecoides.

11. The method of claim 1 , wherein the endogenous fatty acyl-ACP thioesterase gene is ablated.

12. The method of claim 11 , wherein the Prototheca or Chlorella cell is of the species Prototheca moriformis or Chlorella protothecoides.

13. The method of claim 12 , wherein the Chlorella or Prototheca cell further comprises one or more expressed exogenous genes that encode a sucrose invertase, a fatty acyl-ACP thioesterase or a desaturase.

14. The method of claim 13 , wherein the one or more expressed exogenous genes encode(s) an inhibitory RNA that targets an endogenous desaturase.

15. The method of claim 6 , wherein the endogenous fatty acyl-ACP thioesterase gene is ablated.

16. The method of claim 15 , wherein the one or more expressed exogenous genes encode(s) sucrose invertase, fatty acyl-ACP thioesterase or desaturase.

17. The method of claim 16 , wherein the one or more expressed exogenous genes encode(s) an inhibitory RNA that targets an endogenous desaturase.

18. The method of claim 17 , wherein the Prototheca or Chlorella is of the species Prototheca moriformis or Chlorella protothecoides.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 3, 2017
From: TERRAVIA HOLDINGS, INC.
To: CORBION BIOTECH, INC.
Reel/Frame 044424/0211 →
Continuity (7)
Continuation 14730671 · Jun 4, 2015
Continuation 13288815 · Nov 3, 2011
Provisional Application 61546932 · Oct 13, 2011
Provisional Application 61522231 · Aug 10, 2011
Provisional Application 61438966 · Feb 2, 2011
Provisional Application 61409902 · Nov 3, 2010
Related Publication 20160376617A1 · Dec 29, 2016
Cited By (1)
US 12,257,818